Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its ...

Rivian (NASDAQ: RIVN) and Lucid (NASDAQ: LCID) could benefit from increasing tariffs impacting larger car companies more severely. *Stock prices used were the afternoon prices of April 6, 2025. The ...

Tesla (NASDAQ:TSLA) led the electric vehicle sector higher on Wednesday after President Donald Trump dropped new tariff rates on imports from most U.S. trade partners to 10% for 90 days to set up more ...

Where there's smoke, there's fire, and it's clear that Tesla has hit a speed bump due to previously mentioned developments.

Lucid Diagnostics (LUCD) has announced the pricing of a public offering of 12.5 million shares of its common stock at $1.20 per share, for gross proceeds of approximately $15 million.

Lucid Diagnostics (LUCD) announced its intention to offer shares of common stock through an underwritten public offering. Proceeds from the ...

Lucid Diagnostics shares were down 24%, to $1.25, after the company, a subsidiary of PAVmed, priced its underwritten public offering of 12.5 million shares at $1.20 a share.

While the new policy excludes China which now faces an increased U.S. tariff rate of 125% investors appeared optimistic that negotiations between the U.S. and China could resume.

King Salman Energy City (KSBC) has announced the ground-breaking of a 180,000 sq m facility by National Energy Services ...

Macquarie upgraded Atlassian Corp Plc (NASDAQ:TEAM) to "Outperform" from "Neutral" pointing to growing cross-departmental adoption, favourable near-term revenue catalysts, and an improved valuation ...

Lucid Diagnostics Inc. shares (LUCD) tumbled more than 21% in after-hours trading Wednesday after the medical diagnostics ...